Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 1-year, Risedronate-free, Multicenter, Outpatient, Phase IIIb Extension Study to Assess Bone Turnover Recovery in Women With Postmenopausal Osteoporosis Who Sequentially Completed Clinical Studies RVE009093, RVE1996077, and RVE1998080 (no NCT Study Numbers)

NCT01249261 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.

NCT NCT01249261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01249261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 1-year, Risedronate-free, Multicenter, Outpatient, Phase IIIb Extension Study to Assess Bone Turnover Recovery in Women With Postmenopausal Osteoporosis Who Sequentially Completed Clinical Studies RVE009093, RVE1996077, and RVE1998080 (no NCT Study Numbers)
Lead sponsor
Warner Chilcott
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2001
Completion date
May 31, 2003
Enrollment
61 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal women with osteoporosis